Skip to main content
Download PDF

Association of the availability of pharmaceutical facilities provided in secondary and tertiary hospitals with clinical pharmacists’ work performance

BMC Health Services Research volume 23, Article number: 1361 (2023) Cite this article

Abstract

Background

Clinical pharmacists always work as the pivotal role in the process of facilitating the proper use of drug. Based on the person-environment fit theory, the availability of facilities required in pharmaceutical service may influence pharmacists’ performance, but which of them may have positive or negative impact remains unclear.

Objectives

This study aims to analysed the quantitative association of the availability of pharmaceutical facilities provided in Chinese hospitals and clinical pharmacists’ work performance to assist hospitals formulating plans of the improving pharmaceutical working conditions to enhance clinical pharmacists’ performance.

Method

Demonstrated by the panel of expert and literature review, the questionnaire for administrators and clinical pharmacists of secondary and tertiary hospitals in China was formed. Then a mixed sampling was adopted to gather data on information of the participants, as well as evaluation indexes of the availability of facilities and clinical pharmacists’ work performance.

Results

Overall, 625 questionnaires distributed to administrators of hospitals and 1219 ones distributed to clinical pharmacists were retrieved. As for the Pharmaceutical facilities, while the increased availability of Traditional Chinese medicine pharmacy (p = 0.02) has a significantly positive impact on clinical pharmacists’ performance, the great availability of the preparation room (p = 0.07) negatively influences their work performance.

Conclusion

Improving the availability of facilities that significantly influence clinical pharmacists’ work performance possibly reduce their workload, enhance their efficiency and further promote progress in pharmaceutical service.

Peer Review reports

Introduction

Clinical pharmacists always work as the pivotal role in the process of facilitating the proper use of drug. Their work performance referring to the extent to which their work is carried out, which significantly influence the diagnosis and evaluation of the diseases, the proper design and implementation of drug treatment regimens, as well as the assessment and feedback of treatment outcomes [1, 2]. Although the current pharmaceutical service conditions in China’s hospitals have been increasingly improved, there are still problems such as clinical pharmacists’ work not receiving the attention and recognition of hospital administrators [3], and their status, position, and fundamental rights in hospitals not being guaranteed as they should be [4]. With the competency of clinical pharmacists in Chinese hospitals, the hospitals’ conditions to support their work seems to be defective, which may cause errors and omissions in prescription or dispensing [5], further bringing negative influence to pharmacists’ work performance.

As one of the classical sociological theories, person-environment fit theory has been widely applied to study how different roles behave to achieve their goals in particular conditions [6]. According to this theory, the adaptability between objective conditions supplied and individual demand in pharmaceutical service system means the extent of the objective working conditions supporting that clinical pharmacists actually assume their responsibilities [7]. The objective conditions for clinical pharmacists’ work mainly refer to pharmacy professionals’ workplace and the availability of required facilities [8,9,10]. The availability of facilities required in clinical pharmacists’ work would affect their performance [11], and limited availability can be one of the major obstacles for them to implement pharmaceutical services [12].

At present the relationship between the availability of facilities required in clinical pharmacists’ work and their performance has received scant attention. There have been researches reckoned that factors like the development of pharmacy’s construction possibly feature prominently when clinical pharmacists carry out their work [13,14,15]. A few studies around the world emphasize the availability of facilities like residential aged care facilities [16,17,18], long-term care facilities [19], correctional facilities [20], supportive living and assisted living memory care facilities [21] are important for clinical pharmacists to provide outstanding service for specific populations. In developed countries, advanced pharmaceutical facilities are of great attention. For example, the appropriate facilities and equipment to ensure a sterile product are necessary conditions for pharmacists to dispense complex compoundings [22]. In developing countries, the preparedness of basic pharmaceutical facilities like dispensing pharmacy, medicine storage [23] and emergency pharmacy [24] positively influences pharmacists’ work performance. However, so far, no studies have obtained concrete evidence to confirm what detailed facilities provided by medical intuitions might have a positive or negative impact on the performance of pharmacists in China. Moreover, it is difficult to reach a definitive conclusion with indirect evidence such as review of availability of facilities used in clinical pharmacists’ work. Without clarifying the impact of various facilities on the performance of clinical pharmacists, it is hard to reduce the workload of clinical pharmacists and improve their work motivation and efficiency in a targeted and focused manner, so as to improve the level of pharmacy services [25, 26]. In addition, current studies also have limitations such as research objects originating from hospitals at all levels causing the sample devoid of specificity [27,28,29,30], or all subjects being chosen from tertiary hospitals in first-tier cities with better economic development causing the sample lacking representativeness, and the sample size being too small [31, 32].

Applying the person-environment fit theory, this study analyses the adaptivity mechanism between objective conditions and demand of objective humans through conducting survey among wider sample. This study analyses the the quantitative relationship between the availability of pharmaceutical facilities provided by medical institutions and the work performance of clinical pharmacists through empirical research on administrators and clinical pharmacists in secondary and tertiary hospitals in China. It aims to assist hospitals formulate plans of the improving pharmaceutical working conditions to enhance clinical pharmacists’ performance.

Method

Study design

This was a cross-sectional survey of pharmacists, which was designed to collect the data of the availability of pharmaceutical facilities provided in secondary and tertiary hospitals as well as the work performance of clinical pharmacists. The health care system in China follows a 3-tier hierarchical structure, but this research only considered pharmacists from secondary and tertiary hospitals because clinical pharmacy services are mainly provided in the two level of hospitals, which account for more than half of the health care burden in China [25, 33]. Ordinary least squares regression was used to assess the association of each independent variable with clinical pharmacists’ work performance.

Participants

The research was conducted from July to August in 2019. Involving surveyed participants were administrators and clinical pharmacists in Chinese hospitals. The inclusion criteria were as follows: first, the inclusion criteria of hospital administrators was (1) being appointed as the director or deputy director in charge of hospital pharmacy work or the section chief of the pharmacy department of the sampled hospitals; second, the inclusion criteria of clinical pharmacists were (1) working as full-time clinical pharmacists of the sampled hospitals; (2) undertaking specific duties involving management of pharmaceuticals, patients, or medical information. Clinical pharmacists in training (students on clerkships or internships) and visiting clinical pharmacists were excluded.

Moreover, these two groups of survey objects should be available and willing to participate in the study by completing the questionnaire that would take approximately 20–30 min. And they should be able to sign the informed consent document [34, 35].

A mixed sampling strategy was adopted. First, all 31 provincial administrative regions (including provinces, autonomous regions, and municipalities directly under the central government) in mainland China were covered in the sampling [36]. Next, cities in each province, autonomous region or district in each municipality were evenly divided into 3 groups according to their 2018 per capita gross domestic product, for this index was associated with the factors such as the quality of health care techniques and utilization of health care influencing the working ability and conditions of medical staffs. Thereby, 93 groups were generated. Within each group, 1 city or district was selected using the random number method; thus, 93 cities or districts were selected through the multi-staged sampling. In each selected city or district, 2 to 4 tertiary hospitals were surveyed by convenience based on the hospital administrators’ permission to conduct the survey. In each hospital surveyed, 2 hospital manager, and 4 clinical pharmacists were recommended by the hospital administrators who first contacted the investigator or other participants who completed the questionnaire. Overall, 372 hospitals would be sampled and a total of 744 hospital administrators and 1488 clinical pharmacist questionnaires were distributed in this study.

Instrument

An expert panel of 2 administrators and 2 teaching clinical pharmacists from tertiary hospitals, together with 3 experts in clinical pharmacy education from universities, were consulted for the design of the study questionnaire. The questionnaire comprised 3 sections: information of the participants, the availability of pharmaceutical facilities, and clinical pharmacists’ work performance among which the second section would be filled by the hospital administrators and the third section would be filled by clinical pharmacists.

Information of the participants

Pharmacists’ gender, age, marital status, seniority, professional title, specialized field and the feature of hospitals were set as the covariant. These factors are potentially related to clinical pharmacists’ work performance based on literature studies [37].

Evaluation index of the availability of facilities required in pharmaceutical work

The required availability of pharmaceutical facilities in hospitals were summarized according to domestic related laws and regulations including Good Pharmacy Practice (GPP) and Regulations of Pharmaceutical Administration in medical institutions. Demonstrated by the panel of experts, evaluation index system of 11 items concerning facilities required in clinical pharmacists’ routine work was formed, which was presented to participants as “Has the hospital where you work been availed with the facilities in the following list” and with a response of “Yes” or “No”. According to the advice of the expert panel, clinical pharmacists probably be unable to provide the information about the availability of pharmaceutical facilities required for this study, while the administrators of medical institutions would be more familiar with this matter or be able to obtain this information more conveniently. Therefore, this part of the questionnaire was filled by medical work administrators.

Evaluation index of clinical pharmacists’ work performance

Existing instruments for evaluating the work achievement of specialists in pharmacy are only appropriate for pharmacists in social drugstore. Besides, their content is limited to the service that directly access to patients [38, 39]. They do not involve the assessment of the comprehensive responsibilities of clinical pharmacists. As a result, there was no existing suitable instrument for measuring the performance of clinical pharmacists in hospitals in China. Based on the practice guidelines for pharmacotherapy specialists issued by American College of Clinical Pharmacy (ACCP), guidelines on a standardized method for pharmaceutical care issued by American Society of Health-System Pharmacists (ASHP) and regulations on the Administration of Pharmaceutical Affairs in Chinese Medical Institutions together with literature review and expert panel interview, ultimately 12 items were concluded to represent all routine work of clinical pharmacists in Chinese hospitals. Each item was presented to participants as, “Have you ever undertaken the task?” with a response of a 5-level Likert scale, ranging from 1 (strongly disagree) to 5 (strongly agree). It was the total score that was included in regression analysis.

Pre-test

All instruments were composed in Chinese or translated to Chinese and proofed by the expert panel and researchers, followed by a multi-round pilot survey in tertiary hospitals in Nanjing, Jiangsu province, China, to test their rationality, understandability, and readability. The pilot participants for each round met the general inclusion criteria for the study [36]. Five or six Participants were included in each pilot study. After each round, revisions involving polishing the expression of the questions to improve their readability were made according to the feedback. The pilot process continued until no new feedback was generated. Eventually, 4 rounds of pilot tests were completed. Because before the termination of the pilot study, there had been still some problems negatively influence the understandability of the questionnaire, the results received before were meaningless. Responses received during all pilot tests were not included in the final stage of data collection.

Subsequently, a pre-test of the questionnaire was conducted among 47 clinical pharmacists from 24 tertiary hospitals in 6 cities of Jiangsu province in China during April 2019 by convenience sampling. Reliability of the instrument for the clinical pharmacists’ work performance was acceptable (Cronbach’s alpha 0.63 for work performance instrument). The final questionnaire is available online as Additional file 1.

Data collection

A total of 184 undergraduate students majoring in general pharmacy or clinical pharmacy were recruited as data collectors. They were trained to be able to access the potential participants and be familiar with the procedure of conducting the survey and the standardized explanations for potential questions from the participants. Every 2 data collectors investigated 1 set of geographically neighbouring cities or districts in pairs during July and August of 2019. After obtaining the hospital administrators’ consent, the data collectors asked the potential participants for their basic information to determine whether they meet the study inclusion criteria. Then they informed the eligible participants of the purposes, contents, and requirements of the survey and confirmed their willingness to participate again. Those who were willing to participate signed the consent form and decided the time and an undisturbed place for survey with the data collectors.

The data collectors orally interviewed the participants with each item of the questionnaire and recorded their responses through an online survey system installed on mobile phones or tablet computers. The online survey system would convert the data into electronic documents. The data collectors were not allowed to provide any view on the questionnaire, except the requirements or instructions of questionnaire filling. The survey system allowed the users to set restrictions on format of responses and ensured the quality of the data. A total of 5 postgraduates were recruited and trained to review the uploaded documents and immediately return those with data entry errors or damaged data, which were corrected through return visits by data collectors when possible [36].

Data analysis

The dependent variable of this study was the work performance of clinical pharmacists. Because of the uncertainty of the 12 items’ devotion to the dependent variable, the following approach was adopted to determine the weight of each item, thereafter the weighted total score was used to represent the value of the dependent variable [40, 41]. (1) Conducting principal component factor analysis on 12 questions to obtain the principal component coefficients of each question. (2) If the variance contribution rate of the first principal component is relatively high, the final weight is obtained by normalizing this principal component coefficient. (3) Otherwise, the second and third principal components should be taken into account, each of which would be weighted based on the variance contribution rate. The coefficient of the principal component in each principal component will be divided by the corresponding characteristic root square and multiplied by this weight, and finally all the principal component coefficients of the question items will be normalized to get the final weight.

The main variable of the independent variables was the availability of facilities required in clinical pharmacists’ work, and the covariate included the gender, age, marital status, seniority, technical title, professional field and feature of hospitals of respondents. Descriptive statistics were used to report the characteristics of the sample. Ordinary least squares regression was used to assess the association of each independent variable with clinical pharmacists’ work performance. Multicollinearity was assessed by examining the variance inflation factor (VIF). An independent variable with a VIF value more than 10 means that it has collinearity within the other independent variables and should be removed. VIF was examined again when an independent variable with the highest VIF more than 10 was removed. This was repeated until multicollinearity was not suspected any more. Three levels of statistical significance were set in this study, namely p < 0.1, p < 0.05, p < 0.01. Stata 15.0 was used for data analysis.

Result

Overall, 625 questionnaires distributed to hospital administrators were filled out completely (response rate = 84.00%). The feature of sampled hospitals was shown in Table 1.

Table 1 The feature of sampled hospitals
Full size table

Totally 1219 questionnaires distributed to clinical pharmacists were finally received (response rate = 81.48%). The main characteristics of participants are found in Table 2. The mean age of the participants was 35.72(SD = 7.16), and their mean years of practicing as a clinical pharmacist was 10.11(SD = 7.22). Approximately two-thirds of the participants were female (65.14%) and most were married (83.02%). More than half of the participants were with junior technical title (34.94%) or intermediate title (51.12%).

Table 2 Sociodemographic data of clinical pharmacists
Full size table

The availability of facilities in surveyed hospitals can be seen in Table 3. As for various facilities, outpatient pharmacies (100.0%), inpatient pharmacies (94.56%), pharmaceutical warehouse (98.24%), Chinese medicine clinics (94.24%) were generally available, which existed in almost all the surveyed hospitals. On the other hand, the data and information department (65.28%), the centralized intravenous drug dispensing room (50.56%), the preparation room (43.04%), the drug testing room (41.92%) and the pharmacy research room (29.76%) were limitedly available in Chinese hospitals.

Table 3 The availability of facilities
Full size table

In Table3, laboratory of the control of drug is responsible for the inspection of semi-finished products, finished products, raw materials, and purchased drugs in the hospital, and is in charge of the quality management of drugs. As for substandard products, clinical pharmacists assist in analyzing the reasons for non-compliance by gaining a deeper understanding of the manufacturing process, and they will conduct technical reviews if necessary.

Clinical pharmacists in laboratory for research of drug conducts research and development work on new drugs, formulations, and dosage forms based on the medical, teaching, and scientific research needs within the hospital. In details, they conduct research on drug properties, dosage forms, drug quality, drug interactions, and compatibility contraindications, and they also should pay attention to pharmacokinetic, bioavailability, and toxicological studies.

Department of information is responsible for provide consultation information for clinical use. Staff here should master the development trends of domestic and international pharmacy, collecting and categorizing pharmaceutical information materials in time.

The results of principal component analysis of clinical pharmacists’ work performance scores were shown in Table 4. The KMO score was 0.889 and scree plot was shown in Fig. 1. The characteristic roots of the first three principal components were greater than 1, and the cumulative variance contribution rate was 59.37%. First, the coefficient of each question item in each principal component was divided by the sum of the corresponding principal component coefficients, and the absolute values of the results were calculated. Second, the percentages of variance of each principal were divided by the cumulative percentages of these principal components, so the variance’ contribution rate of each principal component were obtained. Thirdly, absolute values calculated in the first step were multiplied by the variance’ contribution rates correspondingly. The final weight corresponding to each question item was obtained after the results of the step three were divided by the sum of the them. And the comprehensive score of each sample is calculated accordingly.

Table 4 Weight of items to evaluate the clinical pharmacists’ work performance
Full size table
Fig. 1
figure 1

The scree plot of PCs

Full size image

The results of regression analysis was provided in Table 5. In case of facilities provided in hospitals, the traditional Chinese medicine pharmacy (Coef. = 0.22, p = 0.02, 95%CI = [0.03, 0.41]) has a significantly positive impact on the actual work of clinical pharmacists, the preparation room (Coef. = -0.13, p = 0.07, 95% CI = [-0.28, 0.01]) had a significantly negative impact on clinical pharmacists’ performance. Whether there is a drug researching department (Coef. = 0.1, p = 0.08, 95%CI = [-0.01, 0.21]) has certain significant correlation with the actual work carried out by the participants.

Table 5 Regression analysis of the availability of facilities’ association with clinical pharmacists’ work performance
Full size table

The result of the multiple regression model used in the study: y = 3.24 + 0.01x1 + 0.00x2 + (-0.13)x3 + 0.07x4 + 0.1x5 + (-0.1)x6 + 0.05x7 + (-0.02)x8 + 0.22x9 + 0.06x10 + 0.06x11 + 0.01x12 + (-0.01)x13 + (-0.01)x14 + 0.03x15 + 0.05x16 + 0.00x17 + 0.00x18 + ε.Footnote 1

Discussion

This study analysed the association of the availability of pharmaceutical facilities provided in hospitals with clinical pharmacists’ work performance. Multi-staged sampling was adopted to cover a wide range of sample so as to ensure it being highly representative. According to the results, among all facilities probably required in clinical pharmacists’ work, the availability of Traditional Chinese Medicine (TCM) pharmacy, the preparation room and drug researching room has significant impact on their work performance.

The reasons for the availability of the TCM pharmacy brings beneficial influence to clinical pharmacists’ performance may lies in two aspects. For one thing, it can play a positive role in case of the prescription consisted of both Chinese herbs and modern drugs. In such a circumstance, clinical pharmacists need to cooperate with other members of the medical team to perform their duties including assessment of patients’ drug demand, optimization of drug composition, and adjustment of drug dosage, etc. [42]. The combined treatment of traditional Chinese medicine and western medicine not only enhance the curative effect while reducing the adverse reaction but also increase intractability of administration of drug [43]. In general hospitals, it is common that patients consult more than one department to diagnose and treat different diseases, where doctors may write out complex prescriptions. Setting up the TCM pharmacy provides a platform for patients to conveniently consult the methods or precautions of taking decoction with Chinese patent medicine or taking traditional Chinese medicine with western medicine [44]. It is also beneficial for clinical pharmacists to learn about patients’ demand of drug comprehensively and further accurately evaluate the safety and effectiveness of the medication regimen [45]. Therefore, either adverse reactions caused by the interaction of Chinese herbs and modern drug or toxic side effect caused by overdose resulting from repeatedly administration can be effectively avoided. Apart from the patients, some physicians would like to turn to clinical pharmacists in TCM pharmacy to recognize the unfamiliar herb or uncomprehending point in prescriptions of traditional Chinese medicine which may be borrowed from other hospitals, so as to avoid incompatibility in practice [46]. Moreover, physicians may not master the proper use of rare and toxic Chinese medicines [47], and in such a circumstance, the TCM pharmacy provides a suitable place for clinical pharmacists to adjust the prescription dosage according to the individual conditions of patients. For another, the availability of TCM pharmacy makes it possible for clinical pharmacists to provide high-quality service like decocting herbal medicine [48], dispensing decocted pieces and preparing non-decocted granules [49] which can avoid the loss of drug efficacy caused by patients’ unscientific operation in the process of decocting as much as possible [50], thus improving the economy and rationality of drug treatment.

On the other hand, the availability of the preparation room has significant negative influence on clinical pharmacists’ work performance. It has been reported that since 2019, based on investigation on whether hospitals with drug approval numbers have established a preparation room [51], the facility has been removed from many hospitals. The reason for the phenomenon may lie in the fact that with the continuous improvement of the national standards for preparations of medical institutions, the limited size and obsolete equipment of hospitals’ preparation room hardly satisfy the requirements of manufacturing of drug and it was finally reduced to be closed [52]. Besides, with the increasing variety of drugs mushrooming on the domestic market, there are also cases where preparations of some medical institutions are gradually replaced by similar products sold on the market [53]. Inadequate facilities probably result in clinical pharmacists hardly striving for perfection at pharmaceutical preparation work constantly. The preparations made in medical institutions are directly related to clinical practice for they can be adjusted in time to meet clinical demand. Also, this practice can reduce the cost of circulation. And some of specific preparations are attached with definite curative efficacy, which have irreplaceable outstanding advantages [51]. Therefore, the medical institutions may be reminded to properly increase the investment in preparation room to expand its scale, standardize preparations’ production, provide good conditions for clinical pharmacists to carry out related work, promoting the innovative development of hospital preparations.

Outpatient pharmacy, inpatient pharmacy, etc. are common ancillary facilities needed in pharmaceutical service, which, however, have no significant impact on the work performance of clinical pharmacists in this study. Maybe because these facilities were introduced early in Chinese hospitals to develop considerable operational experience and have gradually applied artificial intelligence(AI) for automation transformation [54, 55]. Advanced technology helps to reduce pharmacists’ repeated work like delivering, supplementing and checking drug [56, 57], so they can devote themselves to pharmaceutical service demanding professional knowledge and skills such as prescription consultation in the TCM pharmacy and dispensing in the preparation room. Moreover, AI offers potential opportunities to optimize clinical pharmacy services in community or hospital settings. AI powered apps and tools currently play a positive role in clinical pharmacy services including medication order review, health product dispensing, storage and management of information about patients’ medical histories etc. [58, 59]. Clinical pharmacists need to keep abreast of these developments in order to position themselves optimally while maintaining their human relationships with healthcare teams and patients.

This study has some limitations. First, the instrument used to measure or evaluate the availability of facilities in secondary and tertiary hospitals and clinical pharmacists’ work performance was put into practice in large-scale research only after being verified by small samples from several tertiary hospitals in Jiangsu Province. But the data obtained from the large-scale research validated the instrument’s measuring effect. Second, since it seems impractical to randomly sample clinical pharmacists in the secondary and tertiary hospitals in China, convenience sampling was used in the multi-staged sampling procedure which may have led to a biased sample. Third, during the process of empowering weight to items of dependent variables, though the selected three principal components’ characteristic square root were all greater than 1, their cumulative variance contribution rate is 59.37%. Therefore, these three components may not fully represent the overall characteristics, resulting in a certain deviation between the weighted total score and the actual value.

Conclusions

This study analysed the association of the availability of pharmaceutical facilities provided in Chinese hospitals and clinical pharmacists’ work performance. The results demonstrated that the availability of TCM pharmacy and drug researching room could significantly improve clinical pharmacists’ performance; while the availability of the preparation room might have certain negative impact on their work performance. These results may provide some evidence for hospitals to improve the performance of clinical pharmacists by increasing the availability of required facilities. The medical institutions may be supposed to design a specific ground for consultation of integrated use of Chinese and western medicine and purchase necessary equipment for decoction, in order to help pharmacists in TCM pharmacy provide high quality pharmaceutical service. Also, administrators of the hospitals are reminded to properly increase the investment in preparation room to expand its scale, standardize preparations’ production, so as to neutralize its negative impact on clinical pharmacists’ work performance.

Availability of data and materials

The datasets generated and/or analysed during the current study are not publicly available, because data used in this research is part of a larger data set exclusively constructed with the authors’ efforts, and this data set is to be used in the authors’ other researches, which required confidentiality. But they are available from the corresponding author on reasonable request.

Notes

  1. x1: Emergency pharmacy, x2: Inpatient pharmacy, x3: Preparation room, x4: Laboratory of the control of drug, x5: Laboratory for research of drug, x6: Medicine store, x7: Clinical pharmacy, x8: Department of information, x9: Traditional Chinese medicine pharmacy, x10: Pharmacy of intravenous admixture service, x11: Level of hospitals, x12: Types of hospitals, x13: gender, x14: Marital status, x15: Technical title, x16: Educational background, x17: Age, x18: Years of practice.

Abbreviations

TCM:

Traditional Chinese Medicine

References

  1. Pharmacy ACoC. Standards of practice for clinical pharmacists. Pharmacotherapy. 2014;34(8):794–7.

    Article  Google Scholar 

  2. Ballerie A, Alix L, Bajeux E, Jégo P, Lescoat A, Hue B. The collaboration of clinical pharmacists and physicians for medication safety. Lancet. 2019;394(10216):2240.

    Article  PubMed  Google Scholar 

  3. Hua L. Development and improvement of clinical pharmacy and specialized clinical pharmacist in our hospital. Chin Pharm J. 2010;21(18):1636–40.

    Google Scholar 

  4. Fangfang L, Li D, Peng S, Hao W, Bo Y. Research on the work status quo and countermeasures of pharmacists in public hospitals of Chongqing under the background of “new medical reform.” Chin Pharm J. 2019;30(24):3350–4.

    Google Scholar 

  5. Xiaobo C. Causes and preventive measures of prescription dispensing errors in hospital pharmacy. Mod Med China. 2016;14(12):8–9.

    Google Scholar 

  6. Stone RP, Leuty ME, Rayburn R, Wu BH. Person–environment fit at work: relationships with workplace behaviours. Aust J Career Dev. 2019;28(3):234–44.

    Article  Google Scholar 

  7. Harrison R. Person-environment fit and job stress. New York: Wiley; 1978.

    Google Scholar 

  8. McDonough RP, Doucette WR. Developing collaborative working relationships between pharmacists and physicians. J Am Pharm Assoc. 2001;41(5):11.

    Google Scholar 

  9. Zillich AJ, Doucette WR, Carter BL, Kreiter CD. Development and initial validation of an instrument to measure physician-pharmacist collaboration from the physician perspective. Value Health. 2005;8(1):59–66.

    Article  PubMed  Google Scholar 

  10. Bradley F, Ashcroft DM, Noyce PR. Integration and differentiation: a conceptual model of general practitioner and community pharmacist collaboration. Res Social Adm Pharm. 2012;8(1):36–46.

    Article  PubMed  Google Scholar 

  11. Schafheutle EI, Seston EM, Hassell K. Factors influencing pharmacist performance: a review of the peer-reviewed literature. Health Policy. 2011;102(2–3):178–92.

    Article  PubMed  Google Scholar 

  12. MacCallum L, Mathers A, Kellar J, et al. Pharmacists report lack of reinforcement and the work environment as the biggest barriers to routine monitoring and follow-up for people with diabetes: a survey of community pharmacists. Res Social Adm Pharm. 2021;17(2):332–43.

    Article  PubMed  Google Scholar 

  13. Xiaoyu X, Dongning Y, Yuankai H, Xiaojing W, Yitao W, Wenbing Y. National survey on clinical pharmacy services of tertiary hospitals in China: part 1. Introduction of survey and basic conditions of clinical pharmacy service provision. Chin Pharm J. 2017;2(35):2.

    Google Scholar 

  14. Xiaoyu X, Dongning Y, Yuankai H, Mengqing L, Xiaojing W, Yitao W, Wenbing Y. National survey on clinical pharmacy services of second-level hospitals in China: part 1. Introduction of survey and basic conditions of clinical pharmacy service provision. Chin Pharm J. 2018;53(23):7.

    Google Scholar 

  15. Fan Y. Relevant thinking of problems based on the clinical pharmacy services. Clin Res Pract. 2017;2(35):2.

    Google Scholar 

  16. Batten M, Kosari S, Koerner J, Naunton M, Cargo M. Evaluation approaches, tools and aspects of implementation used in pharmacist interventions in residential aged care facilities: a scoping review. Res Social Adm Pharm. 2022;18(10):3714–23.

    Article  PubMed  Google Scholar 

  17. Haider I, Naunton M, Davey R, Peterson GM, Baqir W, Kosari S. How do pharmacists practice in aged care? A narrative review of models from Australia, England, and the United States of America. Int J Environ Res Public Health. 2021;18(23):12773.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Batten MKS, Koerner J, Naunton M, Cargo M. Evaluation approaches, tools and aspects of implementation used in pharmacist interventions in residential aged care facilities: a scoping review. Res Social Adm Pharm. 2022;18(10):10.

    Article  Google Scholar 

  19. Plüss-Suard CNA, Héquet D, Krähenbühl S, Pichon R, Zanetti G, Bugnon O, Petignat C. Decrease in antibacterial use and facility-level variability after the introduction of guidelines and implementation of physician-pharmacist-nurse quality circles in Swiss long-term care facilities. J Am Med Dir Assoc. 2020;21(1):6.

    Article  Google Scholar 

  20. Thomson CGM, Macek P. Clinical pharmacists in correctional facilities: a literature review and future directions. J Correct Health Care. 2019;25(3):13.

    Article  Google Scholar 

  21. Haas MA, Haas L, Knoke K, Andreski M. Rural physician-pharmacist collaborative practice agreements managing patients in supportive living and assisted living memory care facilities. Innov Pharm. 2019;10(4). https://doi.org/10.24926/iip.v10i4.1371.

  22. Stoner N. Are UK hospital pharmacy departments ready for the rise of gene therapy medicinal products? Expert Opin Biol Ther. 2018;18(8):837–40.

    Article  PubMed  Google Scholar 

  23. Meena DK, Jayanthi M, Ramasamy K, Thulasingam M. Medicine storage and dispensing facilities in public healthcare pharmacies of Puducherry, India. Cureus. 2022;14(1):e21389.

    PubMed  PubMed Central  Google Scholar 

  24. Aljabri A, Bakhsh H, Baageel A, et al. Hospital pharmacy preparedness and pharmacist role during disaster in Saudi Arabia. Risk Manag Healthc Policy. 2021;14:5039–46.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Xiaoyu X, Dongning Y, Yuankai H, Xiaojing W, Yitao W, Wenbing Y. National Survey on Clinical Pharmacy Services of Tertiary Hospitals in China: Part 2. Staffing of Clinical Pharmacist Team. Chin Pharm J. 2018;53(10):472-46.

    CAS  Google Scholar 

  26. Shuhong P, Haitao L, Ping L, Lixia L, Jian Z. Establishment and practice of pharmaceutical care quality evaluation systems of clinical pharmacists in our hospital. Chin Pharm J. 2013;24(05):421–4.

    Google Scholar 

  27. Ming H, Xuehua J, Yongpei W, Qing Y, Xixi L. Survey of status quo of hospital pharmaceutical services and clinical pharmacy in china (part 1): general situation of hospital pharmaceutical services. Chin Pharm J. 2009;20(01):72–4.

    Google Scholar 

  28. Ming H, Xuehua J, Yongpei W, Qing Y, Xixi L. Survey on hospital pharmaceutical care in China and the status quo of clinical pharmacy practice (part 2): survey on status quo of clinical pharmacy practice. Chin Pharm J. 2009;20(13):1030–2.

    Google Scholar 

  29. Ming H, Lingli Z, Xuehua J, Yongpei W, Qing Y, Xixi L. Survey of hospital pharmaceutical care in China and the status quo of clinical pharmacy practice (part 3): attitude of the personnel involved in clinical pharmacy. Chin Pharm J. 2009;20(16):1278–80.

    Google Scholar 

  30. Zhanwang H, Biao L, Zhiming Z, Rixing P, Hong H. Survey of current situation of hospital pharmaceutical services in 50 hospitals in Maoming area. Asia Pac Tradit Med. 2014;10(07):133–5.

    Google Scholar 

  31. Yuan X, Xin L. Investigation and analysis on the current situation of clinical pharmacy service in tertiary general hospitals. J Nanjing Med Univ Soc Sci. 2016;16(1):5.

    Google Scholar 

  32. Cuiling Z. Investigation and analysis on the current situation of clinical pharmacy service in tertiary general hospitals. Electron J Clin Med Lit. 2016;3(22):3.

    Google Scholar 

  33. Cui L, Xiaoyu X, Dongning Y, Yuankai H, Yitao W, Wenbing Y. National survey on clinical pharmacy services of tertiary hospitals in China: part 3. Status quo of clinical pharmacy service provision. Chin Pharm J. 2018;53(10):837-42

    Google Scholar 

  34. Yuankai H, Dongning Y, Hongjie Z, Xiaoyu X, Yitao W, Wenbing Y. Association of hospital pharmacy-related knowledge and skills with occupational stress of clinical pharmacists in tertiary hospitals of China. J Am Pharm Assoc. 2021;61(3):266–75.

    Article  PubMed  Google Scholar 

  35. Miao S. Surveying the working pressure on medical staffs and its causes. Chin Health Serv Manag. 2011;28:2.

    Google Scholar 

  36. Yuankai H, Yanhai L, Meiling L, Xinxin W, Tian W, Xiaoyu X, et al. National survey on pharmaceutical care of primary healthcare institutions in China: part 3. Status quo of pharmaceutical care provision. Chin J Hosp Pharm. 2019;39(02):109–15.

  37. Yong FR, Garcia-Cardenas V, Williams KA, Charlie Benrimoj SI. Factors affecting community pharmacist work: a scoping review and thematic synthesis using role theory. Res Social Adm Pharm. 2020;16(2):123–41.

    Article  PubMed  Google Scholar 

  38. El Hajj MS, Al-Saeed HS, Khaja M. Qatar pharmacists’ understanding, attitudes, practice and perceived barriers related to providing pharmaceutical care. Int J Clin Pharm. 2016;38(2):330–43.

    Article  PubMed  Google Scholar 

  39. Yu F, Shimin Y, Bianling F, Yufei N, Kanghua Z. Pharmacists’ perception of pharmaceutical care in community pharmacy: a questionnaire survey in China. In: Paper presented at: 2010 China Pharmaceutical Congress and the 10th China Pharmacist Week. Tianjin: Chinese Pharmaceutical Association; 2010.

  40. Jinghua L, Yaohuang G. Principal component evaluation--a multivariate evaluate method expanded from principal component analysis. J Ind Eng Eng Manag. 2002;16(01):39–43+33.

  41. Yu Y. Evaluation and analysis of weighting methods in multi index comprehensive evaluation. Stat Decis. 2006;13:17–9.

    CAS  Google Scholar 

  42. Ningning W, Ying D, Huaqiang Z. Rational application of combination of Chinese and Western medicines. In: Paper presented at: The Second Congress of Clinical Chinese Medicine. Beijing: Jiangxi Chinese Traditional Medicine Association; 2018.

  43. Hai X, Linfeng Z. On safety risk factors of Chinese patent medicine. Chin Pharm J. 2011;22(15):1436–8.

    Google Scholar 

  44. Dongmei W, Yonggang F, MATong. Practice and experience of developing medicine consultation service in Chinese traditional medicine of a general hospital. Pharm Today. 2015;25(10):718–20.

    Google Scholar 

  45. Chengkun H, Guifen Z, Huixian H, Muxia S, Wenneng L. Discussion on clinical pharmacy of traditional Chinese medicine. J Tradit Chin Med. 2018;26(05):73–6.

    Google Scholar 

  46. Qionghua S. Examination of prescription of traditional Chinese medicine and rational clinical drug use. Chin Pharm J. 2007;03:229–30.

    Google Scholar 

  47. Daowen Y, Yueqing W. Practice and experience of developing pharmaceutical service in Chinese herbal pharmacy. Shanghai Med Pharm J. 2009;30(05):228–9.

    Google Scholar 

  48. Dongqing W, Yali Z. Management and construction of decocting pharmacy. Forum Tradit Chin Med. 2010;25(05):39–40.

    Google Scholar 

  49. Liping W. Introduction of Decoted-free granules made of Chinese herbal medicine. World Latest Med Inf. 2016;16(17):163+165.

    Google Scholar 

  50. Wenxing H. Talking about decoction of traditional Chinese medicine. In: Paper presented at: 2011 Academic Annual Meeting of Jiangxi Society of Traditional Chinese Medicine. Nanchang: Chinese Pharmaceutical Association; 2011.

  51. Genguang C, Qingfen W, Jinshan C. Standardized management of manufacturing laboratory equipment in comprehensive hospital. Chin Med Equip J. 2017;38(12):146–8.

    Google Scholar 

  52. Mingyuan C, Cuilia Z, Liang Z, Qing Y, Wei Z. Nationwide investigation and problems analysis of pharmaceutical preparations in medical institutions. Chin Pharm J. 2022;33(05):513–8.

    Google Scholar 

  53. Lin S, Xu C, Yu Z, Lixin Z, Wen T, Quan Z. Analysis on the problems and countermeasures of hospital preparations in Beijing. Chin Hosp. 2015;19(04):57–9.

    Google Scholar 

  54. Jingquan C, Yan L. Practice and establishment of smart outpatient pharmacy. Herald Med. 2022;41(09):1393–6.

    Google Scholar 

  55. Yan L, Zhibo C, Mengshan H, Xiangbo G, Gang Y. Evaluation of development status and application effect of outpatient pharmacy automatic dispensing system in Mainland China. Chin J Mod Appl Pharm. 2020;37(09):1131–8.

    Google Scholar 

  56. Sensen W, Yun Z. Application of intelligent access system in quantitative drug management of inpatient pharmacy of pharmacy department. J Tradit Chin Med Manag. 2022;30(06):183–5.

    Google Scholar 

  57. Chuxuan H, Siyu Z, Linglin L, Wenzhou D, Suihua L, Xia Z, JIa Q, Qinghua M. Optimization drug withdrawal model in the inpatient pharmacy by information system management. Pharm Today. 2022;32(07):540–2+548.

    Google Scholar 

  58. Ranchon F, Chanoine S, Lambert-Lacroix S, Bosson J-L, Moreau-Gaudry A, Bedouch P. Development of artificial intelligence powered apps and tools for clinical pharmacy services: a systematic review. Int J Med Inform. 2023;172:104983.

    Article  PubMed  Google Scholar 

  59. Raza MA, Aziz S, Noreen M, et al. Artificial intelligence (AI) in pharmacy: an overview of innovations. Innov Pharm. 2022;13(2). https://doi.org/10.24926/iip.v13i2.4839.

Download references

Acknowledgements

The authors thank the expert panel for valuable advice related to study design and the pharmacists who participated in the survey. This paper would not be accomplished without their efforts.

STROBE statement

The authors have read the STROBE guidelines, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.

Funding

This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.

Author information

Authors and Affiliations

  1. China Pharmaceutical University School of International Pharmaceutical Business, No. 639, Longmian Avenue, Jiangning District, Nanjing, Jiangsu Province, 211198, China

    Rong Cai, Xiaoyu Xi & Yuankai Huang

Authors
  1. Rong Cai
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Xiaoyu Xi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yuankai Huang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Xi xiaoyu designed and revised the content of the questionnaire used in the research. Cai Rong and Huang Yuankai organised and collected data acquisition. Cai Rong developed the analysis model. All authors have contributed to the final version of the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Yuankai Huang.

Ethics declarations

Ethics approval and consent to participate

The ethical approval to conduct the pilot survey, pre-test and main survey was granted by the Ethics Committee of China Pharmaceutical University (Project Number: CPU2019015). All methods of the study were carried out in accordance with the ethical standards of the Ethics Committee of China Pharmaceutical University and the principles of CFDA-GCP and the Helsinki Declaration. Written informed consent to participate was signed by all participated.

Consent for publication

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Additional file 1.

Questionnaire.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Cai, R., Xi, X. & Huang, Y. Association of the availability of pharmaceutical facilities provided in secondary and tertiary hospitals with clinical pharmacists’ work performance. BMC Health Serv Res 23, 1361 (2023). https://doi.org/10.1186/s12913-023-10390-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12913-023-10390-1

Keywords

BMC Health Services Research

ISSN: 1472-6963

Contact us